UCCF-853 - Moligand™ , Activator of CFTR, CAS No.625458-06-2, Activator of CFTR

CAS: 625458-06-2 Cat. No.: U614615 PubChem CID: 17750928
注文可能
グレード&純度 Moligand™ ? Moligand™ — Aladdin's line of ligands and bioactive small molecules. Use for receptor, pathway, and binding studies needing defined small-molecule tools.
Synonyms
1-(3-chlorophenyl)-5-trifluoromethyl-3-hydrobenzimidazol-2-one|1-(3-Chlorophenyl)-5-(trifluoromethyl)-1,3-dihydro-2H-benzimidazol-2-one|1-(3-chlorophenyl)-5-(trifluoromethyl)-2,3-dihydro-1H-1,3-benzodiazol-2-one|UCCF-853|1-(3-Chlorophenyl)-1,3-dihydro-5-(trifluoromethyl)-2H-Benzimidazol-2-one|1-(3-chlorophenyl)-5-trifluoromethyl-1,3-dihydrobenzoimidazol-2-one|3-(3-chlorophenyl)-6-(trifluoromethyl)-1H-benzimidazol-2-one
Storage
Room temperature
★
サイズ
USA
ドイツ (EU)*
価格
個数
5mg
U614615-5mg
受注生産 · 8~12週間
$799.90
25mg
U614615-25mg
受注生産 · 8~12週間
$1,199.90
Enter a quantity for the sizes you want to add.

仕様

同義語
1-(3-chlorophenyl)-5-trifluoromethyl-3-hydrobenzimidazol-2-one | 1-(3-Chlorophenyl)-5-(trifluoromethyl)-1,3-dihydro-2H-benzimidazol-2-one | 1-(3-chlorophenyl)-5-(trifluoromethyl)-2,3-dihydro-1H-1,3-benzodiazol-2-one | UCCF-853 | 1-(3-Chlorophenyl)-1,3-dihydro-5-(trifluoromethyl)-2H-Benzimidazol-2-one | 1-(3-chlorophenyl)-5-trifluoromethyl もっと見る
仕様と純度
Moligand™
保管条件
Room temperature
等級
Moligand™
アクションタイプ
ACTIVATOR
作用メカニズム
Activator of CFTR
名前と識別子
SMILES
C1=CC(=CC(=C1)Cl)N2C3=C(C=C(C=C3)C(F)(F)F)NC2=O
IUPAC Name
3-(3-chlorophenyl)-6-(trifluoromethyl)-1H-benzimidazol-2-one
InChIKey
NMPJFFWYEIIGFW-UHFFFAOYSA-N
InChI
1S/C14H8ClF3N2O/c15-9-2-1-3-10(7-9)20-12-5-4-8(14(16,17)18)6-11(12)19-13(20)21/h1-7H,(H,19,21)
異性体SMILES
C1=CC(=CC(=C1)Cl)N2C3=C(C=C(C=C3)C(F)(F)F)NC2=O
代替CAS番号
625458-06-2
PubChem CID
17750928

詳細データ

Taxonomic Classification

Taxonomy Tree

KingdomOrganic compounds
SuperclassOrganoheterocyclic compounds
分類Benzimidazoles
SubclassPhenylbenzimidazoles
Intermediate Tree Nodes Not available
Direct ParentPhenylbenzimidazoles
Alternative Parents Phenylimidazoles  Chlorobenzenes  N-substituted imidazoles  Aryl chlorides  Heteroaromatic compounds  Ureas  Azacyclic compounds  Organooxygen compounds  Organonitrogen compounds  Organofluorides  Organochlorides  Organic oxides  Hydrocarbon derivatives  Alkyl fluorides  
Molecular FrameworkAromatic heteropolycyclic compounds
Substituents Phenylbenzimidazole - 1-phenylimidazole - Chlorobenzene - Halobenzene - Aryl chloride - Aryl halide - Monocyclic benzene moiety - N-substituted imidazole - Benzenoid - Heteroaromatic compound - Azole - Imidazole - Urea - Azacycle - Organic oxide - Organohalogen compound - Alkyl fluoride - Organochloride - Organic oxygen compound - Organic nitrogen compound - Organofluoride - Hydrocarbon derivative - Organonitrogen compound - Alkyl halide - Organooxygen compound - Aromatic heteropolycyclic compound
説明This compound belongs to the class of organic compounds known as phenylbenzimidazoles. These are compounds containing a phenylbenzimidazole skeleton, which consists of a benzimidazole moiety where its imidazole ring is attached to a phenyl group.
External Descriptors Not available
3 D構造
インタラクティブ化学構造モデル





関連ターゲット(人間)
CFTR Tclin Cystic fibrosis transmembrane conductance regulator (0 Activities)
Activity TypeActivity Value -log(M)Mechanism of ActionActivity ReferencePublications (PubMed IDs)
証明書(CoA、COO、BSE/TSEと分析図)
C of A & Other Certificates(BSE/TSE, COO):
Analytical Chart:
化学的性質と物理的性質
分子量312.67
XLogP33.800
Hydrogen Bond Donor Count1
Hydrogen Bond Acceptor Count4
Rotatable Bond Count1
Exact Mass312.028 Da
Monoisotopic Mass312.028 Da
Topological Polar Surface Area32.299 Ų
Heavy Atom Count21
Formal Charge0
Complexity418.000
Isotope Atom Count0
Defined Atom Stereocenter Count0
Undefined Atom Stereocenter Count0
Defined Bond Stereocenter Count0
Undefined Bond Stereocenter Count0
The total count of all stereochemical bonds0
Covalently-Bonded Unit Count1
ソリューション計算機
レビュー

顧客レビュー

Application Protocols

No vendor-tested applications or protocols are provided for UCCF-853.

General protocols for small-molecule screening stocks (not item-specific):

  • DMSO stock preparation: Weigh compound quickly in a low-humidity environment. Prepare 10–50 mM in anhydrous DMSO. Vortex, sonicate, and, if necessary, warm gently (≤40 °C) until fully dissolved. Record exact concentration and lot.
  • Aliquoting: Dispense single-use aliquots (e.g., 10–50 µL) into low-binding tubes or 384-well source plates. Seal with foil; store protected from light if chromophoric.
  • Assay setup: Add compound to assay plates to reach desired final concentration curve (e.g., 10-point 1:3 serial dilution), keeping carrier solvent constant across wells. Include positive and negative controls and vehicle-only wells.
  • Data quality: Check for fluorescence/absorbance interference by running no-enzyme/no-cell controls. Use detergent or counter-assays to detect aggregation or redox artifacts.

For any specialized application (e.g., chemoproteomics, photoaffinity labeling), first confirm the presence of suitable functional groups in the structure and validate compatibility.

Biological Roles

No biological function or target annotation is provided for UCCF-853 in the product data. As supplied, it is a research chemical intended for screening and discovery workflows and should not be interpreted as having a defined physiological role.

General notes for small-molecule libraries (not item-specific):

  • Library members may be designed to occupy fragments of protein binding sites or to span physicochemical space for hit discovery. Any putative biological role must be established empirically for the specific structure and target via validated assays.
  • If using as a probe, confirm selectivity, potency, and cellular activity through orthogonal methods (biochemical vs. biophysical vs. cellular readouts), and include proper inactive analogs where possible.

Important: Do not infer mechanism of action, target class, or pathway involvement without structure and primary data. Consult the CoA/structure file and your screening results for any preliminary hypotheses.

Buffer Applications

This product is a small organic compound, not a buffering agent. Consequently, classic buffer-system guidance (pH ranges, recipes) does not apply.

Practical notes for assay buffers when using small-molecule stocks (general, not item-specific):

  • Maintain constant carrier solvent percentage across wells (e.g., 0.1–1.0% DMSO) to avoid solvent-driven effects.
  • Include detergent (e.g., 0.01–0.05% Tween-20) to mitigate colloidal aggregation if relevant to assay format.
  • Adjust ionic strength and pH to the biology of the target; confirm compound stability at the chosen pH by LC or UV.
  • Filter and degas buffers for HTS to reduce bubbles and particulates that can affect readouts.

For any buffer-related property that depends on the compound’s ionization (pKa), consult the structure and determine experimental pKa or computational predictions before optimizing assay conditions.

Green Alternatives

This section typically discusses greener substitutes for solvents or reagents. UCCF-853 is a discrete small molecule (library ligand), not a process solvent or commodity reagent; therefore, substitution is not straightforward.

General sustainability considerations for screening compounds:

  • Solvent choice for stocks: Prefer water-miscible, lower-toxicity options where feasible. While DMSO is common, consider minimizing DMSO percentage in assays, and evaluate ethanol or PEG-400/water blends when compatible with the biology and compound stability.
  • Miniaturization: Use low-volume dispensing (acoustic or pin tools) to reduce solvent and plastic consumption.
  • Waste management: Segregate DMSO- and acetonitrile-containing waste for optimized disposal. Plan batchwise assay runs to minimize partially used plates and expired solutions.

Illustrative comparison (general; not item-specific)

  • DMSO vs ethanol as carrier: DMSO offers broader solvency but higher potential for assay perturbation; ethanol is greener but often has poorer solvency for hydrophobic ligands and lower permissible v/v in cells.

Conclusion: Apply green lab practices around handling and solvent usage. No compound replacement is applicable for this item.

Pharmaceutical Uses

No excipient role, pharmacopeial monograph, or manufacturing specification is provided for UCCF-853. It is sold for research use only and is not intended for use in humans or as a component in drug products.

General considerations for discovery workflows (not item-specific):

  • Early formulation screening for in vivo research is out of scope for this research-use-only material. If pre-formulation studies are contemplated in non-clinical settings, verify regulatory grade requirements and re-source material with appropriate GMP documentation.
  • For in vitro ADME profiling, prepare accurately quantified DMSO stocks; ensure compound stability in microsomal or plasma matrices before running assays. These activities remain research-only and do not imply suitability for therapeutic applications.

Conclusion: There are no pharmaceutical or clinical uses claimed or implied for this item.

Physical Properties

Item-specific values

  • Appearance: Not specified for this item; refer to CoA/Spec Sheet.
  • Melting point: Not specified for this item; refer to CoA/Spec Sheet.
  • Boiling point: Not specified for this item; refer to CoA/Spec Sheet.
  • Density: Not specified for this item; refer to CoA/Spec Sheet.
  • Solubility: Not specified for this item; refer to CoA/Spec Sheet.
  • logP/logD: Not specified for this item; refer to CoA/Spec Sheet.
  • pKa: Not specified for this item; refer to CoA/Spec Sheet.
  • Refractive index: Not applicable/unknown for this solid/unspecified form.

General/literature guidance (not item-specific)

  • Small-molecule screening ligands are commonly supplied as solids or film-coated residues suitable for dissolution in polar aprotic solvents (e.g., DMSO) to prepare concentrated stocks (10–50 mM). Actual solubility depends on functional groups (basic amines, acidic heterocycles) and overall polarity.
  • Hygroscopicity or polymorphism may influence handling; if material cakes or shows oiling-out upon warming, gently dry under vacuum at ambient temperature to avoid thermal stress.
  • If aqueous work is intended, co-solvent systems (DMSO/H2O, acetonitrile/H2O) and pH adjustment may be required to achieve clarity; filter through 0.22 µm if particulates remain.

Note: For quantitative properties relevant to your lot (e.g., exact solubility, melting point), consult the Certificate of Analysis (CoA) or request a technical data sheet.

Quality and Grades

Item-specific

  • Grade/Purity: Moligand™ (brand designation). Exact purity specification: Not specified for this item; refer to CoA/Spec Sheet.
  • Stabilizers/inhibitors: Not specified for this item; refer to CoA/Spec Sheet.

What Moligand™ signifies (general information)

  • Moligand-branded items are intended for discovery chemistry and screening workflows, emphasizing compound identity, consistency, and compatibility with assay preparation (e.g., DMSO stock solutions). While specific thresholds are not listed here, such products typically include analytical identity confirmation (e.g., LC/MS) and are suitable for screening and hit-follow-up contexts. Always verify the CoA for your lot to see which tests (NMR, LC purity, MS) were performed.

Practical implications for users

  • For screening campaigns, confirm lot identity and assay readiness by reviewing: analytical purity (% by LC), residual solvent profile, water content (Karl Fischer), and structural confirmation. If any parameters are critical to your method (e.g., UV background for photometric assays, metal content for catalysis), request the specification.
  • If UV transparency or low fluorescence background is required, ask for chromatographic UV traces and fluorescence profiles to pre-qualify for your detection modality.

Documentation to consult: CoA, batch analytical report, and SDS for the purchased lot.

Reaction and Applications

Item-specific manufacturer applications

  • Not provided beyond the category designation (small-molecule/compound library). No specific reaction use cases are listed for this item.

General applications for Moligand-type library members

  • Assay development and high-throughput screening (HTS): Preparation of DMSO stocks for biochemical or cell-based assays to identify primary hits.
  • Chemoproteomics and target deconvolution (with derivatization): If the structure allows, analogs may be equipped with affinity or photo-crosslinking handles for pulldown studies. This item’s suitability depends on its actual functional groups (not specified here).
  • SAR exploration: Use as a reference point within a series if related analogs are available; ensure consistent stock handling to minimize variability.

Practical tips

  • Prepare fresh aliquots to minimize freeze–thaw; validate concentration by UV-Vis or quantitative NMR if assay sensitivity is high.
  • Filter solutions (0.22 µm PTFE) prior to HTS dispensing to reduce clogging.
  • Track plate maps carefully and include vehicle controls (matching DMSO %). Assess compound interference (aggregation, fluorescence, redox cycling) using orthogonal assay formats.

Note: No specific synthetic transformations are claimed for this item due to missing structural information.

Reaction Conditions

Item-specific reaction conditions cannot be provided because the structure and reactive functional groups of UCCF-853 are not disclosed in the product data.

General laboratory handling conditions for small-molecule solutions (not item-specific):

  • Stock prep: Dissolve in anhydrous DMSO to 10–50 mM; vortex and sonicate as needed. Warm gently (≤40 °C) for difficult cases. Verify concentration by weight and volumetry; optionally confirm by UV or qNMR.
  • Assay dilution: Add to aqueous buffers with vigorous mixing to reach the target final DMSO percentage (commonly 0.1–1.0% v/v). Inspect for precipitation; if present, increase co-solvent or reduce concentration.
  • Stability checks: Run short-term stability at room temperature and at 4 °C over assay duration (e.g., 24–72 h) using LC or UV to detect degradation.

If synthetic transformations are intended, first obtain structural information, then consult literature for reaction-specific temperatures, catalysts, and solvents appropriate to the functional groups present. Without structure, yields and times cannot be responsibly estimated.

Safety and Handling

Regulatory/SDS status

  • Research use only. Not for human or veterinary use.
  • GHS classification, signal word, H-statements, and pictograms: Not specified for this item; refer to SDS.

General laboratory precautions (applicable to unknown organic small molecules)

  • Use appropriate PPE: lab coat, safety glasses, and chemically resistant gloves (e.g., nitrile). Handle in a fume hood to avoid inhalation of dust or solvent vapors during dissolution.
  • Avoid contact with skin, eyes, and clothing. Prevent ingestion and inhalation. Wash thoroughly after handling.
  • Incompatibilities cannot be defined without structure; as a general rule, separate organic compounds from strong oxidizers, strong acids/bases, and reducing agents until specific compatibility is known.

First-aid overview (consult SDS for authoritative guidance)

  • Inhalation: Move to fresh air; seek medical advice if symptoms persist.
  • Skin/eye contact: Rinse with plenty of water for at least 15 minutes; remove contaminated clothing; seek medical attention if irritation continues.
  • Ingestion: Rinse mouth; do not induce vomiting; seek medical attention.

Spill/leak and waste

  • Collect solids with minimal dust generation; absorb solutions with inert material. Dispose of waste following institutional and local regulations for organic chemical waste.

Note: Always review the lot-specific SDS before first use to confirm hazards and recommended controls.

Solvent Selection

Item-specific solubility

  • Not specified for this item; refer to CoA/Spec Sheet.

General guidance for screening compounds

  • Primary solvent: DMSO is the default for preparing concentrated stocks (e.g., 10–50 mM) due to broad solvency and assay compatibility at ≤1% final v/v.
  • Secondary solvents: DMF, acetonitrile, ethanol, and isopropanol can assist solubilization; consider co-solvent systems (e.g., DMSO:water 1:3 to 1:9) for aqueous assays.
  • pH tuning: For weak bases, acidic aqueous buffers (e.g., citrate, acetate) can improve solubility; for weak acids, mildly basic buffers (e.g., Tris) may help. Confirm compound stability across pH prior to use.

Selection tips

  • Start with DMSO, verify clarity after vortex/sonication. If undissolved, warm gently (≤40 °C) and/or add a miscible co-solvent (ACN, MeOH), then dilute into buffer with vigorous mixing to avoid precipitation.
  • Avoid adsorptive losses by using low-binding plastics or glass vials; pre-wet pipette tips with solvent.

Comparison (general)

  • DMSO: best solvency, high boiling point; may affect some enzyme assays at >1%.
  • Acetonitrile: volatile, LC-MS friendly; lower solvency for highly lipophilic bases.
  • Ethanol/IPA: biologically tolerated at low %; may extract plasticizers.

Always confirm lot-specific solubility/stability experimentally.

Storage and Reconstitution

Item-specific

  • Storage conditions: Room temperature (as provided). If long-term storage is anticipated, many users keep sealed solids at ambient, desiccated conditions to limit hydrolysis/oxidation; confirm with CoA for this item.
  • Shipped in: Not specified for this item; refer to CoA/Spec Sheet.

General best practices (not item-specific)

  • Solid storage: Keep tightly closed in original container, protected from moisture and light. Use a desiccator or dry cabinet if hygroscopicity is suspected.
  • Reconstitution: Prepare concentrated DMSO stock (e.g., 10–50 mM). Mix thoroughly and confirm clarity. Filter through 0.22 µm PTFE if particulates persist.
  • Aliquoting and stability: Create single-use aliquots to avoid repeated freeze–thaw. Store DMSO stocks at −20 °C to −80 °C unless stability data indicate ambient tolerance; minimize exposure to air and light. Thaw at room temperature, mix, and use promptly.
  • Aqueous solutions: Prepare fresh prior to use unless stability is documented. Avoid prolonged room-temperature storage of aqueous dilutions.

For lot-specific guidance (e.g., known sensitivity to moisture, light, or air), consult the CoA/SDS. Always label aliquots with concentration, solvent, date, and lot number.

Structure and Identity

Item-specific (from Product Data)

  • Product name: UCCF-853 (SKU: U614615)
  • CAS: 625458-06-2
  • PubChem CID: 17750928
  • InChIKey: 242453 (as provided; appears non-standard/incomplete)
  • SMILES: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular formula: Not specified for this item; refer to CoA/Spec Sheet.
  • Molecular weight: Not specified for this item; refer to CoA/Spec Sheet.

Structural features

  • Not available in the provided data. Without a SMILES/InChI or structure, specific functional groups, ring systems, or stereochemistry cannot be detailed for this item.

2D structural description (general guidance)

  • For screening-library ligands like UCCF-853 (Moligand grade), structures commonly comprise heteroaromatic cores and drug-like fragments designed for target engagement; however, the exact motif for this item is not specified. Please consult the CoA or structure file (SDF/SMILES) associated with this CAS/CID for precise visualization and substructure analysis.

Best practice

  • Before experimental use, obtain the vendor structure file and verify identity by independent methods where appropriate (e.g., HRMS, 1H/13C NMR) to confirm the correct lot and structural integrity.
Synthetic Utility

The specific structure of UCCF-853 is not provided in the product data; therefore, concrete synthetic transformations, functional-group compatibility, and named-reaction contexts cannot be assigned for this item.

General perspectives for library compounds (not item-specific):

  • If the structure contains common handles (e.g., aryl halides, anilines, carboxylic acids, nitriles), it could potentially serve as a building block for analog synthesis via cross-coupling (Suzuki, Buchwald–Hartwig), amide coupling, or nucleophilic substitutions. Confirmation requires the actual structure.
  • For SAR expansion, typical late-stage diversification strategies include C–H functionalization, heteroatom alkylation/acylation, and click chemistry (azide–alkyne) if corresponding motifs exist.
  • Purification and analysis: Employ LC-MS guided fractionation, reverse-phase chromatography for polar/ionizable species, and crystallization or normal-phase where applicable.

Recommendation: Obtain the full structure (SMILES/SDF) and analytical data from the CoA to plan any derivatization or synthetic elaboration.

Target Specificity

No target specificity, binding data, or selectivity profile is provided for UCCF-853 in the product data.

Notes:

  • Do not assume activity against any target class without empirical evidence. Any claims of specificity must be supported by validated assay results and structure-confirmed materials.
  • If you identify activity in your campaign, consider profiling against a representative panel of off-targets to assess selectivity and potential liabilities (e.g., frequent hitter behavior, PAINS, redox cyclers).

よくある質問

What is Moligand??
Moligand? is one of Aladdin Scientific's premium product lines, formulated for high-purity applications across multiple workflows. Compared to standard grades in the same workflow, Moligand? products typically offer tighter specifications, more rigorous QC, and stronger lot-to-lot consistency.
How should this product be stored?
Store at room temperature.
What are the CAS number, molecular formula and molecular weight?
The CAS Number is 625458-06-2. InChIKey NMPJFFWYEIIGFW-UHFFFAOYSA-N.
What documentation is provided?
Available product documentation, including Certificates of Analysis (COA), Safety Data Sheets (SDS), and specification sheets, is shown in the product document area. Document availability and access follow the current site policy.

グレードの選択でお困りですか?

当社のグレード選定ガイドでは、カタログ内のすべてのバリエーションについて、純度、安定剤の状態、用途への適合性を網羅しています。

Moligand™ グレードガイドを見る →

Shall we send you a message when we have discounts available?

Remind me later

Thank you! Please check your email inbox to confirm.

Oops! Notifications are disabled.